Eli Lilly and Company (LLY)

Payables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cost of revenue (ttm) US$ in thousands 14,596,700 14,142,000 13,900,900 13,245,000 13,521,600 14,108,300 13,737,000 14,343,500 14,399,600 13,711,200 13,658,000 12,724,900 11,912,100 9,731,900 9,384,100 9,410,800 9,654,600 10,060,000 10,724,200 11,438,700
Payables US$ in thousands 2,598,800 2,435,100 2,474,200 2,015,900 1,930,600 1,683,200 1,659,300 1,433,300 1,670,600 1,566,800 1,597,800 1,639,600 1,606,700 1,430,100 1,247,200 1,207,700 1,405,300 1,114,900 1,198,900 1,168,100
Payables turnover 5.62 5.81 5.62 6.57 7.00 8.38 8.28 10.01 8.62 8.75 8.55 7.76 7.41 6.81 7.52 7.79 6.87 9.02 8.95 9.79

December 31, 2023 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $14,596,700K ÷ $2,598,800K
= 5.62

The payables turnover ratio for Lilly(Eli) & Co has been fluctuating over the past eight quarters, ranging from 2.65 to 5.24. In Q4 2023, the payables turnover ratio was 2.73, showing a slight decrease from the previous quarter. This indicates that the company takes approximately 2.73 times to pay off its accounts payable during the fourth quarter of 2023.

Comparing to Q1 2022, where the payables turnover ratio was the highest at 5.24, the trend has been declining since then. A lower payables turnover ratio may suggest that the company is taking a longer time to pay off its suppliers, which could potentially strain its relationships with them if not managed effectively.

Overall, it is important for Lilly(Eli) & Co to closely monitor its payables turnover ratio to ensure efficient management of its accounts payable and maintain positive relationships with its suppliers.


Peer comparison

Dec 31, 2023


See also:

Eli Lilly and Company Payables Turnover (Quarterly Data)